Shichang Miao

2.2k total citations
46 papers, 1.6k citations indexed

About

Shichang Miao is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Shichang Miao has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Shichang Miao's work include Chemokine receptors and signaling (7 papers), Microbial Natural Products and Biosynthesis (4 papers) and Marine Sponges and Natural Products (4 papers). Shichang Miao is often cited by papers focused on Chemokine receptors and signaling (7 papers), Microbial Natural Products and Biosynthesis (4 papers) and Marine Sponges and Natural Products (4 papers). Shichang Miao collaborates with scholars based in United States, Canada and Netherlands. Shichang Miao's co-authors include Raymond J. Andersen, William A. Ayer, Pirow Bekker, Stephen G. Withers, Thomas J. Schall, Martin E. Tanner, Jinlong Chen, Michelle Lindström, R. Marc Learned and Gary Lee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Shichang Miao

45 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shichang Miao United States 22 647 361 346 247 215 46 1.6k
Frank Bennett United States 23 1.2k 1.8× 397 1.1× 251 0.7× 272 1.1× 94 0.4× 75 2.0k
Ying Sun China 24 1.1k 1.6× 222 0.6× 162 0.5× 379 1.5× 57 0.3× 93 2.1k
Quan Zhang China 28 1.3k 2.0× 528 1.5× 165 0.5× 390 1.6× 156 0.7× 83 2.3k
Lise R. Hoth United States 16 1.5k 2.3× 287 0.8× 230 0.7× 171 0.7× 48 0.2× 24 2.2k
My‐Hanh Lam United States 21 857 1.3× 238 0.7× 148 0.4× 388 1.6× 56 0.3× 33 2.0k
Etsu Tashiro Japan 25 1.5k 2.3× 220 0.6× 145 0.4× 236 1.0× 135 0.6× 78 2.1k
Raymond Wu United States 17 1.1k 1.7× 116 0.3× 182 0.5× 146 0.6× 31 0.1× 24 1.9k
Emmanuelle J. Meuillet United States 30 1.7k 2.6× 331 0.9× 288 0.8× 334 1.4× 39 0.2× 65 2.4k
Lawrence M. Ballas United States 24 2.2k 3.5× 548 1.5× 223 0.6× 243 1.0× 75 0.3× 37 3.5k
Yong Yin China 22 699 1.1× 480 1.3× 116 0.3× 97 0.4× 49 0.2× 61 1.4k

Countries citing papers authored by Shichang Miao

Since Specialization
Citations

This map shows the geographic impact of Shichang Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shichang Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shichang Miao more than expected).

Fields of papers citing papers by Shichang Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shichang Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shichang Miao. The network helps show where Shichang Miao may publish in the future.

Co-authorship network of co-authors of Shichang Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Shichang Miao. A scholar is included among the top collaborators of Shichang Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shichang Miao. Shichang Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Shichang, Pirow Bekker, Danielle Armas, et al.. (2024). Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants. Clinical Pharmacology in Drug Development. 13(5). 517–533. 7 indexed citations
2.
Miao, Shichang, et al.. (2024). Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants. Clinical Pharmacology in Drug Development. 13(9). 1011–1023. 2 indexed citations
3.
Miao, Shichang, et al.. (2024). A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants. Clinical and Translational Science. 17(7). e13878–e13878. 3 indexed citations
4.
5.
Sullivan, Kathleen M., Linda Ertl, Zhenhua Miao, et al.. (2022). 499 The small molecule PD-L1 inhibitor CCX559 preferentially accumulates in tumors, resulting in depletion of cell-surface PD-L1 in a murine preclinical model. Regular and Young Investigator Award Abstracts. A520–A520. 1 indexed citations
6.
Miao, Zhenhua, Linda Ertl, Dale Newland, et al.. (2018). CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS). PLoS ONE. 13(3). e0192405–e0192405. 8 indexed citations
7.
8.
Wang, Zhulun, Daqing Sun, Sheree Johnstone, et al.. (2015). Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4. Bioorganic & Medicinal Chemistry Letters. 25(23). 5546–5550. 6 indexed citations
9.
Hezel, Aram F., Ferry A.L.M. Eskens, Stefan Sleijfer, et al.. (2015). Abstract B24: Pharmacokinetic and pharmacodynamic profile of the novel, oral and selective CCR2 inhibitor CCX872-B in a Phase 1B pancreatic cancer trial. Molecular Cancer Therapeutics. 14(12_Supplement_2). B24–B24. 1 indexed citations
10.
Tak, Paul P., Andra Bălănescu, Vira Tseluyko, et al.. (2012). Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial. Annals of the Rheumatic Diseases. 72(3). 337–344. 76 indexed citations
11.
Du, Xiaohui, Darin J. Gustin, Xiaoqi Chen, et al.. (2009). Imidazo-pyrazine derivatives as potent CXCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5200–5204. 29 indexed citations
12.
Liu, Jiwen, Yingcai Wang, Ying Sun, et al.. (2009). Tetrahydroquinoline derivatives as CRTH2 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(24). 6840–6844. 39 indexed citations
13.
Stranz, David D., et al.. (2008). Combined Computational Metabolite Prediction and Automated Structure-Based Analysis of Mass Spectrometric Data. Toxicology Mechanisms and Methods. 18(2-3). 243–250. 14 indexed citations
14.
Shi, Jianxia, et al.. (2007). A fully automated plasma protein precipitation sample preparation method for LC–MS/MS bioanalysis. Journal of Chromatography B. 862(1-2). 219–226. 58 indexed citations
15.
Du, Xiaohui, Xiaoqi Chen, Jason Duquette, et al.. (2007). Design and optimization of imidazole derivatives as potent CXCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(2). 608–613. 26 indexed citations
16.
Lee, Gary, John McNally, Jennifer Weiszmann, et al.. (2002). T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities. Journal of Biological Chemistry. 277(22). 19649–19657. 263 indexed citations
17.
McCarter, John D., David L. Burgoyne, Shichang Miao, et al.. (1997). Identification of Glu-268 as the Catalytic Nucleophile of Human Lysosomal β-Galactosidase Precursor by Mass Spectrometry. Journal of Biological Chemistry. 272(1). 396–400. 32 indexed citations
18.
Miao, Shichang, et al.. (1995). Stawamycin, a new pyrroloketoindane natural product from the cultures of Streptomyces sp.. Tetrahedron Letters. 36(32). 5699–5702. 11 indexed citations
19.
Ayer, William A. & Shichang Miao. (1993). Trehalose Esters from the Aspen Fungus Hyphozyma lignicola. Journal of Natural Products. 56(12). 2046–2052. 3 indexed citations
20.
Miao, Shichang, Raymond J. Andersen, & Theresa M. Allen. (1990). Cytotoxic Metabolites from the Sponge lanthella basta Collected in Papua New Guinea. Journal of Natural Products. 53(6). 1441–1446. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Bennett Breakdown of academic impact, for papers by Ying Sun Breakdown of academic impact, for papers by Quan Zhang Breakdown of academic impact, for papers by Lise R. Hoth Breakdown of academic impact, for papers by My‐Hanh Lam Breakdown of academic impact, for papers by Etsu Tashiro Breakdown of academic impact, for papers by Raymond Wu Breakdown of academic impact, for papers by Emmanuelle J. Meuillet Breakdown of academic impact, for papers by Lawrence M. Ballas Breakdown of academic impact, for papers by Yong Yin
Rankless by CCL
2026